<sentence id="0">Immunosuppressant PG490 ( triptolide ) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation .</sentence>
<sentence id="1">PG490 ( triptolide ) is a diterpene triepoxide with potent immunosuppressive and antiinflammatory properties .</sentence>
<sentence id="2">PG490 inhibits interleukin(IL)-2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12-myristate 13-acetate ( PMA ) and antibody to CD3 ( IC50 of 10 ng/ml ) , and with PMA and ionomycin ( Iono , IC50 of 40 ng/ml ) .</sentence>
<sentence id="3">In Jurkat T-cells , PG490 inhibits PMA/Iono-stimulated IL-2 transcription .</sentence>
<sentence id="4">PG490 inhibits the induction of DNA binding activity at the purine-box/antigen receptor response element (ARRE)/nuclear factor of activated T-cells ( NF-AT ) target sequence but <scope type="neg" id="0"><cue type="neg" id="0">not</cue> at the NF-kappaB site</scope> .</sentence>
<sentence id="5">PG490 can completely inhibit transcriptional activation at the purine-box/ARRE/NF-AT and NF-kappaB target DNA sequences triggered by all stimuli examined ( PMA , PMA/Iono , tumor necrosis factor-alpha ) .</sentence>
<sentence id="6">PG490 also inhibits PMA-stimulated activation of a chimeric transcription factor in which the C-terminal TA1 transactivation domain of NF-kappaB p65 is fused to the DNA binding domain of GAL4 .</sentence>
<sentence id="7">In 16HBE human bronchial epithelial cells , IL-8 expression is regulated predominantly by NF-kappaB , and PG490 but <scope type="neg" id="1"><cue type="neg" id="1">not</cue> cyclosporin A</scope> can completely inhibit expression of IL-8 .</sentence>
<sentence id="8">The mechanism of PG490 inhibition of cytokine gene expression differs from cyclosporin A and involves nuclear inhibition of transcriptional activation of NF-kappaB and the purine-box regulator operating at the ARRE/NF-AT site at a step after specific DNA binding .</sentence>